Company Encyclopedia
View More
name
Balchem
BCPC.US
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates.
444.26 B
BCPC.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
Specialty ChemicalsIndustry
Industry Ranking6/46
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE12.06%B
    • Profit Margin14.72%B
    • Gross Margin35.68%C
  • Growth ScoreB
    • Revenue YoY7.55%B
    • Net Profit YoY22.76%B
    • Total Assets YoY4.01%C
    • Net Assets YoY10.25%B
  • Cash ScoreB
    • Cash Flow Margin679.31%C
    • OCF YoY7.55%B
  • Operating ScoreB
    • Turnover0.62B
  • Debt ScoreA
    • Gearing Ratio21.86%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    VP van Gunsteren Files To Sell 6,000 Of Balchem Corp [BCPC]

    Van Gunsteren Job Leonard, Vice President of Balchem Corp, filed a Form 144 with the SEC on December 4, 2025, to sell 6,000 shares of restricted stock through Charles Schwab & Co Inc. The sale is permitted within 90 days of filing.

    Reuters·
    US
    BCPC
    -0.45%
    Reuters·
    US
    BCPC
    -0.45%

    Balchem Corporation Unveils Study Supporting Iron Levels in Blood Donors

    Balchem Corporation announced findings from the FORTE Study, which supports iron levels in low-ferritin whole blood donors. This study highlights the need for a steady blood supply, as blood cannot be synthetically produced and has a limited shelf life. The timing of the study's presentation was not specified. The news was generated by Public Technologies using AI and is for informational purposes only.

    Reuters·
    US
    BCPC
    -0.45%
    Reuters·
    US
    BCPC
    -0.45%

    Dir Fischer Files To Sell 6,000 Of Balchem Corp [BCPC]

    Fischer David B, Director of Balchem Corp, filed a Form 144 with the SEC to sell 6,000 restricted shares on December 3, 2025. The sale will be conducted through Charles Schwab & Co Inc. Form 144 allows the sale of restricted stock within 90 days of filing.

    Reuters·
    US
    BCPC
    -0.45%
    Reuters·
    US
    BCPC
    -0.45%

    A Fresh Look at Balchem (BCPC) Valuation After Recent Share Price Gains

    Balchem (BCPC) shares have gained 9% in the past month, sparking investor interest. Despite a 11.4% decline in one-year total shareholder return, the five-year return is 54.9%. Analysts suggest Balchem is undervalued, with a fair value of $200.33, compared to the current $156.75. The stock's PE ratio is 34x, above industry averages, indicating a potential premium. Ongoing investments in automation and supply chain flexibility are expected to drive growth, but global trade tensions and slow growth in the animal nutrition segment pose risks.

    Simplywall·
    US
    BCPC
    -0.45%
    Simplywall·
    US
    BCPC
    -0.45%

    Balchem Exec Makes a Bold Move with Stock Sale!

    Martin Luther Reid, Senior VP and Chief Supply Chain Officer at Balchem, sold 1,200 shares worth $185,328. Balchem reported record Q3 2025 financial results with net sales of $267.6M and net earnings of $40.3M. H.C. Wainwright raised the price target to $190. TipRanks’ AI Analyst rates BCPC as Outperform with a stock score of 80, despite potential short-term volatility.

    Tip Ranks·
    US
    BCPC
    -0.45%
    Tip Ranks·
    US
    BCPC
    -0.45%
    © 2025 Longbridge｜Disclaimer